Ledger.Open graph →
SEC Form D · filed August 20, 2024

Cirius Therapeutics, Inc

Offering
$1.3M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GRAND RAPIDS, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Michael Jandernoa · Grand Rapids, MIDirectorRobert Zerbe · Grand Rapids, MIDirectorDavid Van Andel · Grand Rapids, MIDirectorJerry Callahan · Grand Rapids, MIExecMark Olesnavage · Grand Rapids, MIExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗